ES2080941T3 - Nueva vacuna y procedimiento para la misma. - Google Patents

Nueva vacuna y procedimiento para la misma.

Info

Publication number
ES2080941T3
ES2080941T3 ES91903336T ES91903336T ES2080941T3 ES 2080941 T3 ES2080941 T3 ES 2080941T3 ES 91903336 T ES91903336 T ES 91903336T ES 91903336 T ES91903336 T ES 91903336T ES 2080941 T3 ES2080941 T3 ES 2080941T3
Authority
ES
Spain
Prior art keywords
procedure
same
new vaccine
detoxified
pertussis toxin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91903336T
Other languages
English (en)
Inventor
Carine Capiau
Jean Petre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Application granted granted Critical
Publication of ES2080941T3 publication Critical patent/ES2080941T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups

Abstract

SE DESCRIBE UNA TOXINA B.PERTUSSIS DETOXIFICADA O PREPARADO ANTIGENICO, QUE SE CARACTERIZA POR LA ESTABILIDAD A LA REVERSION A LA TOXICIDAD EN ALMACENAMIENTO DE 4-8 (GRADOS) C Y A TEMPERATURAS POR ENCIMA DE 23 (GRADOS) C. TAMBIEN SE PROPORCIONAN METODOS PARA LA PRODUCCION DE UNA TOXINA DE PERTUSSIS DETOXIFICADA Y VACUNAS QUE LA CONTIENEN.
ES91903336T 1990-02-12 1991-02-07 Nueva vacuna y procedimiento para la misma. Expired - Lifetime ES2080941T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47909890A 1990-02-12 1990-02-12

Publications (1)

Publication Number Publication Date
ES2080941T3 true ES2080941T3 (es) 1996-02-16

Family

ID=23902647

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91903336T Expired - Lifetime ES2080941T3 (es) 1990-02-12 1991-02-07 Nueva vacuna y procedimiento para la misma.

Country Status (17)

Country Link
EP (1) EP0515415B1 (es)
JP (1) JP3035712B2 (es)
KR (1) KR100202052B1 (es)
AT (1) ATE129159T1 (es)
AU (1) AU646019B2 (es)
CA (1) CA2075711C (es)
CY (1) CY1935A (es)
DE (1) DE69113991T2 (es)
DK (1) DK0515415T3 (es)
ES (1) ES2080941T3 (es)
GR (1) GR3018440T3 (es)
HK (1) HK1004524A1 (es)
IE (1) IE70672B1 (es)
NZ (1) NZ237069A (es)
PT (1) PT96723B (es)
WO (1) WO1991012020A1 (es)
ZA (1) ZA91947B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122010000015I1 (de) 1992-05-23 2010-07-08 Glaxosmithkline Biolog Sa Kombinierte Impfstoffe, die Hepatitis-B-Oberflächen antigen und andere Antigene enthalten
GB9216351D0 (en) * 1992-07-31 1992-09-16 Wellcome Found Vaccine production
EP1107782B1 (en) * 1998-09-01 2009-12-23 Merrion Research III Limited Oral vaccine compositions
AU769539B2 (en) * 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
GB0313916D0 (en) 2003-06-16 2003-07-23 Glaxosmithkline Biolog Sa Vaccine composition
DK2809343T3 (da) 2012-02-01 2017-11-27 Glaxosmithkline Biologicals Sa Fremgangsmåde til fermentering
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
CA2879939A1 (en) 2012-08-06 2014-02-13 Glaxosmithkline Biologicals S.A. Novel method
MY172181A (en) 2013-03-08 2019-11-15 Janssen Vaccines & Prevention Bv Acellular pertussis vaccine
US9849066B2 (en) 2013-04-24 2017-12-26 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
WO2015018806A1 (en) 2013-08-05 2015-02-12 Glaxosmithkline Biologicals S.A. Combination immunogenic compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075321A (en) * 1973-05-04 1978-02-21 Agence Nationale De Valorisation De La Recherche (Anvar) Vaccines, the process for preparing the same and the applications thereof
JPS5750925A (en) * 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
US4888169A (en) * 1986-10-14 1989-12-19 Norden Laboratories, Inc. Bordetella Bronchiseptica vaccine
AU5027890A (en) * 1989-02-10 1990-09-05 Genesit Oy A method for producing pertussis toxin subunits

Also Published As

Publication number Publication date
IE910424A1 (en) 1991-08-14
DE69113991T2 (de) 1996-03-21
JPH05503936A (ja) 1993-06-24
DE69113991D1 (de) 1995-11-23
PT96723B (pt) 1998-07-31
JP3035712B2 (ja) 2000-04-24
CA2075711C (en) 2000-11-07
IE70672B1 (en) 1996-12-11
AU7211091A (en) 1991-09-03
EP0515415A1 (en) 1992-12-02
ZA91947B (en) 1992-01-29
WO1991012020A1 (en) 1991-08-22
ATE129159T1 (de) 1995-11-15
HK1004524A1 (en) 1998-11-27
KR920703099A (ko) 1992-12-17
KR100202052B1 (ko) 1999-06-15
CA2075711A1 (en) 1991-08-13
NZ237069A (en) 1993-07-27
DK0515415T3 (da) 1995-11-27
AU646019B2 (en) 1994-02-03
GR3018440T3 (en) 1996-03-31
PT96723A (pt) 1991-10-31
EP0515415B1 (en) 1995-10-18
CY1935A (en) 1991-02-07

Similar Documents

Publication Publication Date Title
DE69022106T2 (de) Pertussistoxin-Mutanten, dieselbe produzierende Bordetella-Stämme und ihre Verwendung als Vakzin gegen Pertussis.
NO165478C (no) Fremgangsmaate for fremstilling av antigeniske preparater.
ES2080941T3 (es) Nueva vacuna y procedimiento para la misma.
ES494955A0 (es) Un procedimiento para preparar derivados de fenilpiperidina
DK1666057T3 (da) Fremgangsmåde til fremstilling af en acellulær vaccine indeholdende Bordetella pertussis antigener
DK365287D0 (da) Fremgangsmaade til dyrkning af bordetella pertussis, pertussis toxoid, pertussis vacciner og fremgangsmaade til fremstilling af pertussis vacciner
IT9019914A0 (it) Composti immunogenici,il procedimento per la loro sintesi e loro impiego per la preparazione di vaccini antimalaria
YU303680A (en) Process for preparing benzofurnace derivatives
DK59281A (da) Fremgangsmaade til fremstilling af phenylpiperazinderivater af 1,3,4-oxadiazolylphenolder
CA2004206A1 (en) Method for preparing pertussis toxin toxoid
NO892997L (no) Bordetella pertussis vaksine.
ES2061481T3 (es) Derivados de 3,4-dihidrobenzoazina opticamente activos y procedimiento para la preparacion de los mismos.
DE68917972T2 (de) Pertussistoxoid-Impfstoff.
IT9019286A0 (it) Mutanti della tossina della pertosse, ceppi di bordetella capaci di produrre detti mutanti e loro impiego per lo sviluppo di vaccini antipertosse

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 515415

Country of ref document: ES